Efavirenz use during pregnancy and for women of child-bearing potential

BACKGROUND: Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews evidence of efavirenz tera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chersich, Matthew F, Urban, Michael F, Venter, Francois WD, Wessels, Tina, Krause, Amanda, Gray, Glenda E, Luchters, Stanley, Viljoen, Dennis L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1468418/
https://www.ncbi.nlm.nih.gov/pubmed/16603057
http://dx.doi.org/10.1186/1742-6405-3-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1468418/
https://www.ncbi.nlm.nih.gov/pubmed/16603057
http://dx.doi.org/10.1186/1742-6405-3-11

Ejemplares similares